Vanguard Capital Management’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.2M Buy
602,932
+43,990
+8% +$1.26M ﹤0.01% 2575
2026
Q2
$15.4M Buy
558,942
+68,495
+14% +$1.86M ﹤0.01% 2587
2026
Q1
$13.6M Buy
+490,447
New +$14M ﹤0.01% 2560

Other funds holding ASMB

Vanguard Capital Management's ASMB Position: Q3 2026 in Review

Vanguard Capital Management increased its Assembly Biosciences (ASMB) stake by 7.9% in Q3 2026, buying an estimated $1.26M and bringing the position to 602,932 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

Vanguard Capital Management first reported a position in ASMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.4M in Q2 2026. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • Vanguard Capital Management held 602,932 shares of Assembly Biosciences worth $14.2M as of Q3 2026.
  • Vanguard Capital Management bought 43,990 Assembly Biosciences shares in Q3 2026, an estimated $1.26M.
  • Assembly Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2575 holding.
  • Vanguard Capital Management first reported a position in Assembly Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Assembly Biosciences position peaked at $15.4M in Q2 2026.
  • 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.